Clinical trial

Accelerated Neuromodulation Therapy for Negative Symptoms of Schizophrenia

NCT07428460

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-02-01

PhaseNA

Study timeline

Study start (actual)2026-02-01Date precision: day

Registry last updated2026-08-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophrenia and Predominant Negative Symptomsunresolved

Interventions

Neuronavigated Intermittent Theta Burst StimulationDEVICE

BEAM-F3 Intermittent theta burst stimulationDEVICE

Sham Intermittent Theta Burst StimulationDEVICE

Sponsors & collaborators

Douglas Mental Health University Institutelead sponsor

Centre de recherche CERVOcollaborator

Magnus Medicalcollaborator

Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréalcollaborator

Mapped research locations

MontrealQuebec, Canada1 QuébecQuebec, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07428460 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.